首页 > 市场调查报告书 > 製药

药物开发开发业务受託机关

欧洲药品合约销售组织市场预测至 2030 年 - 区域分析 - 按服务、模组、治疗领域和最终用户

市场调查报告书

商品编码

1494477

欧洲药品合约销售组织市场预测至 2030 年 - 区域分析 - 按服务、模组、治疗领域和最终用户

Europe Pharmaceutical Contract Sales Organizations Market Forecast to 2030 - Regional Analysis - by Services, Modules, Therapeutic Area, and End User

出版日期: 2024年04月05日 | 出版商:

The Insight Partners | 英文 88 Pages | 订单完成后即时交付

价格

简介目录图表

欧洲药品合约销售组织市场预计将从2022年的19.089亿美元成长到2030年的34.7497亿美元。

製药公司对增加产品销售的兴趣日益浓厚，推动了欧洲药品合约销售组织市场

近年来，製药公司越来越多地采用创新策略来增加其产品的销售量。这一领域的一个显着趋势是对药品合约销售组织 (CSO) 的高度依赖，将其作为其商业化努力的关键组成部分。这凸显了製药实体为应对市场复杂性而采取的积极主动的方法。透过与公民社会组织合作，这些公司可以利用专业的销售队伍，利用外部熟练度来提高市场渗透率并优化销售业绩。这种协作模式使製药公司能够简化营运并专注于研发等核心能力，同时利用公民社会组织的客製化专业知识来增强其产品的市场地位。製药公司和公民社会组织之间日益增强的协同反映了对资源优化的细緻入微的理解，体现了对适应性的承诺以及对激烈竞争的製药领域不断变化的动态的敏锐认识。这种共生关係促进了收入最大化，并使製药企业在敏捷性和有针对性的市场策略对于持续成功至关重要的环境中进行策略定位。

欧洲药品合约销售组织市场概况

欧洲药品合约销售组织市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。随着慢性病盛行率的迅速上升、老年人口的不断增加以及各种治疗应用对新药物分子的需求不断增加，以满足未满足的需求，该地区对药品的需求正在显着增长。近 550 家製药公司在德国开展业务。该国的合约销售组织（CSO）为大型製药公司和小型生物技术公司提供服务，帮助他们在欧洲市场取得领先地位。根据德国贸易投资总署的资料，2020年德国药品销售额较2019年成长6.7%，达607.9亿美元（495亿欧元）。近年来，由于生物药物的发展，德国和其他欧洲国家的製药业模式发生了重大变化。因此，生物製剂因其强大的治疗潜力而占据了製药业务的相当大一部分。大公司现在专注于创造复杂的生物化合物，而不是开发小分子药物。

2021年3月，IQVIA与强生公司子公司杨森製药公司之一的Janssen Research & Development, LLC合作进行杨森的COVID-19疫苗的3期临床试验。这些试验结合了远距医疗技术、虚拟监督和数位患者互动策略，利用了 IQVIA 的一系列分散式试验解决方案，并得到了现场和远端研究的支持。 IQVIA 拥有全球最大的商业解决方案组织，致力于推出和行销各种客户产品，该公司在欧洲多个国家都有业务。

欧洲药品合约销售组织市场收入和 2030 年预测（百万美元）

欧洲药品合约销售组织市场区隔

欧洲药品合约销售组织市场分为服务、模组、治疗领域、最终用户和国家。

根据服务，欧洲药品合约销售组织市场分为商业服务和非商业服务。 2022年，商业服务领域在欧洲药品合约销售组织市场中占有更大份额。

根据模组，欧洲药品合约销售组织市场分为联合模组和专用模组。 2022 年，联合模组细分市场在欧洲药品合约销售组织市场中占据更大份额。

根据治疗领域，欧洲药品合约销售组织市场分为心血管疾病、肿瘤、代谢性疾病、神经科、骨科疾病、传染病等。 2022 年，肿瘤学领域在欧洲药品合约销售组织市场中占据最大份额。

根据最终用户，欧洲药品合约销售组织市场分为生物製药公司和製药公司。 2022 年，製药公司细分市场在欧洲药品合约销售组织市场中占有更大份额。

根据国家/地区，欧洲药品合约销售组织市场分为英国、德国、法国、西班牙、义大利和欧洲其他地区。 2022 年，德国在欧洲药品合约销售组织市场占据主导地位。

Aenova Holding GmbH、IQVIA Holdings Inc、MaBico SA、辉瑞公司和 Syneos Health Inc 是欧洲药品合约销售组织市场上的一些领先公司。

In recent years, pharmaceutical companies are increasingly adopting innovative strategies to augment the sales of their products. One notable trend within this landscape is the heightened reliance on pharmaceutical contract sales organizations (CSOs) as a pivotal component of their commercialization endeavors. This underscores a proactive approach by pharmaceutical entities to navigate the complexities of the market. By engaging CSOs, these companies can tap into specialized sales forces, capitalizing on external proficiency to enhance market penetration and optimize sales performance. This collaborative paradigm enables pharmaceutical firms to streamline their operations and concentrate on core competencies such as research and development while concurrently leveraging the tailored expertise of CSOs to bolster their products' market presence. The growing synergy between pharmaceutical companies and CSOs reflects a nuanced understanding of resource optimization, illustrating a commitment to adaptability and a keen awareness of the evolving dynamics within the fiercely competitive pharmaceutical landscape. This symbiotic relationship facilitates revenue maximization and positions pharmaceutical enterprises strategically in an environment where agility and targeted market strategies are paramount for sustained success.

Europe Pharmaceutical Contract Sales Organizations Market Overview

The European pharmaceutical contract sales organizations market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The demand for pharmaceutical products is growing significantly in this region with the burgeoning prevalence of chronic diseases, the rising geriatric population, and increasing demand for new drug molecules for various therapeutic applications to fulfill unmet needs. Nearly 550 pharmaceutical companies have operations in Germany. Contract sales organizations (CSOs) in this country provide their services to large pharmaceutical companies and small-scale biotech companies, assisting them in attaining leading positions in the European market. As per data by Germany Trade & Invest, pharmaceutical sales in Germany increased by 6.7% in 2020 compared to 2019, reaching US$ 60.79 billion (EUR 49.5 billion). The landscape of the pharmaceutical industry in Germany and other European countries has recently undergone significant changes due to the development of biological medications. As a result, biologics have taken up a sizeable portion of pharmaceutical businesses due to their strong therapeutic potential. Large corporations are now concentrating on creating complex biological compounds rather than developing small-molecule drugs.

In March 2021, IQVIA worked with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies, which is a subsidiary of Johnson & Johnson, on the Phase 3 clinical trials of Janssen's COVID-19 vaccine. Combining telehealth technologies, virtual oversight, and digital patient interaction tactics, the trials leveraged IQVIA's array of decentralized trial solutions, which were supported by on-site and remote studies. IQVIA has the world's largest commercial solutions organization dedicated to launching and marketing various clients' products, and the company has presence in various European countries.

Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Million)

Europe Pharmaceutical Contract Sales Organizations Market Segmentation

The Europe pharmaceutical contract sales organizations market is segmented into services, modules, therapeutic area, end user, and country.

Based on services, the Europe pharmaceutical contract sales organizations market is bifurcated into commercial services and non-commercial services. The commercial services segment held a larger share of the Europe pharmaceutical contract sales organizations market in 2022.

Based on modules, the Europe pharmaceutical contract sales organizations market is bifurcated into syndicated modules and dedicated modules. The syndicated modules segment held a larger share of the Europe pharmaceutical contract sales organizations market in 2022.

Based on therapeutic area, the Europe pharmaceutical contract sales organizations market is segmented into cardiovascular disorders, oncology, metabolic disorders, neurology, orthopedic diseases, infectious diseases, and others. The oncology segment held the largest share of the Europe pharmaceutical contract sales organizations market in 2022.

Based on end user, the Europe pharmaceutical contract sales organizations market is bifurcated into biopharmaceutical companies and pharmaceutical companies. The pharmaceutical companies segment held a larger share of the Europe pharmaceutical contract sales organizations market in 2022.

Based on country, the Europe pharmaceutical contract sales organizations market is segmented into the UK, Germany, France, Spain, Italy, and the Rest of Europe. Germany dominated the Europe pharmaceutical contract sales organizations market in 2022.

Aenova Holding GmbH, IQVIA Holdings Inc, MaBico SA, Pfizer Inc, and Syneos Health Inc are some of the leading companies operating in the Europe pharmaceutical contract sales organizations market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Pharmaceutical Contract Sales Organizations Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Europe PEST Analysis

5. Europe Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

5.1 Key Market Drivers
- 5.1.1 Increasing Integration of Digital Technologies
- 5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products
5.2 Key Market Restraints
- 5.2.1 Quality Issues Associated with Outsourcing
5.3 Key Market Opportunities
- 5.3.1 Rising Use of Telemedicine and Remote Detailing
5.4 Key Future Trends
- 5.4.1 Expansion in Emerging Markets
5.5 Impact Analysis:

6. Pharmaceutical Contract Sales Organizations Market - Europe Market Analysis

6.1 Europe Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

7. Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Services

7.1 Overview
7.2 Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
7.3 Commercial Services
- 7.3.1 Overview
- 7.3.2 Commercial Services: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Non-Commercial Services
- 7.4.1 Overview
- 7.4.2 Non-Commercial Services: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Modules

8.1 Overview
8.2 Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
8.3 Syndicated Modules
- 8.3.1 Overview
- 8.3.2 Syndicated Modules: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Dedicated Modules
- 8.4.1 Overview
- 8.4.2 Dedicated Modules: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Therapeutic Area

9.1 Overview
9.2 Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
9.3 Cardiovascular Disorders
- 9.3.1 Overview
- 9.3.2 Cardiovascular Disorders: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Oncology
- 9.4.1 Overview
- 9.4.2 Oncology: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Metabolic Disorders
- 9.5.1 Overview
- 9.5.2 Metabolic Disorders: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Neurology
- 9.6.1 Overview
- 9.6.2 Neurology: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Orthopaedic Diseases
- 9.7.1 Overview
- 9.7.2 Orthopedic Diseases: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.8 Infectious Diseases
- 9.8.1 Overview
- 9.8.2 Infectious Diseases: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.9 Others
- 9.9.1 Overview
- 9.9.2 Others: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by End User

10.1 Overview
10.2 Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
10.3 Biopharmaceutical Companies
- 10.3.1 Overview
- 10.3.2 Biopharmaceutical Companies: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical Companies
- 10.4.1 Overview
- 10.4.2 Pharmaceutical Companies: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Pharmaceutical Contract Sales Organizations Market - Country Analysis

11.1 Europe Pharmaceutical Contract Sales Organizations Market, Revenue and Forecast to 2030

12. Pharmaceutical Contract Sales Organizations Market - Industry Landscape

12.1 Overview
12.2 Growth Strategies
- 12.2.1 Overview

13. Company Profiles

13.1 MaBico SA
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 IQVIA Holdings Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Syneos Health Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Aenova Holding GmbH
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Pfizer Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Europe Pharmaceutical Contract Sales Organizations Market Segmentation
Table 2. UK: Europe Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 3. UK: Europe Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 4. UK: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 5. UK: Europe Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 6. Germany: Europe Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 7. Germany: Europe Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 8. Germany: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 9. Germany: Europe Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 10. France: Europe Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 11. France: Europe Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 12. France: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 13. France: Europe Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. Italy: Europe Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 15. Italy: Europe Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 16. Italy: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 17. Italy: Europe Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. Spain: Europe Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 19. Spain: Europe Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 20. Spain: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 21. Spain: Europe Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Europe: Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Europe: Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Europe: Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 25. Rest of Europe: Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 26. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market
Table 27. Glossary of Terms, Europe Pharmaceutical Contract Sales Organizations Market

List Of Figures

Figure 1. Europe Pharmaceutical Contract Sales Organizations Market Segmentation, By Country
Figure 2. Europe PEST Analysis
Figure 3. Europe Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Europe Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030
Figure 6. Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
Figure 7. Commercial Services: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Non-Commercial Services: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
Figure 10. Syndicated Modules: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Dedicated Modules: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
Figure 13. Cardiovascular Disorders: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Oncology: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Metabolic Disorders: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Neurology: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Orthopedic Diseases: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Infectious Diseases: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 21. Biopharmaceutical Companies: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Pharmaceutical Companies: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Europe Pharmaceutical Contract Sales Organizations Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 24. Europe Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)
Figure 25. UK: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Germany: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. France: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Italy: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Spain: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Rest of Europe: Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)